We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

169 hedge funds and large institutions have $790M invested in Ariad Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 63 increasing their positions, 44 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 44

19% more call options, than puts

Call options by funds: $31.5M | Put options by funds: $26.5M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

7% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 29

1% less funds holding

Funds holding: 171 → 169 (-2)

10% less capital invested

Capital invested by funds: $877M → $790M (-$86.6M)

Holders
169
Holders Change
-2
Holders Change %
-1.17%
% of All Funds
4.86%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
27
Increased
63
Reduced
44
Closed
29
Calls
$31.5M
Puts
$26.5M
Net Calls
+$5.02M
Net Calls Change
+$1.41M

Top Buyers

Rank Fund Capital Flow
1
AQR Capital Management
AQR Capital Management
Connecticut
+$20.4M
2
BFA
BlackRock Fund Advisors
California
+$19.5M
3
Renaissance Technologies
Renaissance Technologies
New York
+$14.8M
4
Norges Bank
Norges Bank
Norway
+$14.6M
5
CCM
Camber Capital Management
Massachusetts
+$13.8M

Top Sellers

Rank Fund Capital Flow
1
SPC
Slate Path Capital
New York
-$53.4M
2
PAI
Palo Alto Investors
California
-$8.14M
3
ARTA
A.R.T. Advisors
New York
-$4.58M
4
Citadel Advisors
Citadel Advisors
Florida
-$3.23M
5
Allianz Asset Management
Allianz Asset Management
Germany
-$2.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$6.27M -$13.2K -1,921 -0.2%
TCIM
27
TIAA CREF Investment Management
New York
$5.55M +$4.03M +586,548 +206%
Group One Trading
28
Group One Trading
Illinois
$4.9M +$2.71M +393,848 +105%
ECP
29
Elk Creek Partners
Colorado
$4M +$2.32M +337,082 +116%
IIM
30
Ironwood Investment Management
Massachusetts
$4M +$69.4K +10,093 +2%
CNB
31
City National Bank
California
$3.98M +$2.22M +323,294 +107%
BNP Paribas Asset Management
32
BNP Paribas Asset Management
France
$3.96M +$682K +99,122 +19%
Axa
33
Axa
France
$3.62M -$79.2K -11,517 -2%
Nomura Holdings
34
Nomura Holdings
Japan
$3.59M -$732K -106,507 -16%
Charles Schwab
35
Charles Schwab
California
$3.51M +$1.7M +246,780 +81%
CA
36
Commerzbank Aktiengesellschaft
Germany
$3.49M +$1.52M +220,604 +67%
PPA
37
Parametric Portfolio Associates
Washington
$3.47M +$344K +50,091 +10%
VanEck Associates
38
VanEck Associates
New York
$3.4M -$931K -135,344 -20%
GC
39
Guggenheim Capital
Illinois
$3.3M -$1.1M -159,799 -24%
Goldman Sachs
40
Goldman Sachs
New York
$3.13M +$618K +89,898 +22%
RA
41
Royce & Associates
New York
$3.06M -$248K -36,000 -7%
BIM
42
BlackRock Investment Management
Delaware
$2.88M +$2.68M +389,172 +626%
GPCM
43
Granite Point Capital Management
Massachusetts
$2.87M -$1.36M -198,000 -31%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$2.78M +$526K +76,547 +21%
CS
45
Credit Suisse
Switzerland
$2.6M +$217K +31,506 +8%
JP Morgan Chase
46
JP Morgan Chase
New York
$2.51M +$1.17M +170,094 +76%
RPAM
47
Rhenman & Partners Asset Management
Sweden
$2.48M +$1.05M +152,190 +64%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$2.46M – – –
MIG
49
Mariner Investment Group
New York
$2.16M +$1.75M +255,000 +301%
U
50
UBS
Switzerland
$2.08M -$1.23M -178,758 -35%
1
2
3 4 5

ARIA Hedge Fund Activity: Q2 2014 in Review

169 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q2 2014, worth a combined $790M — down 9.9% from $877M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ARIA and 27 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 63 added.

The largest buyer was AQR Capital Management, adding an estimated $20.4M. The largest seller was Slate Path Capital, exiting entirely with an estimated $53.4M sold.

  • 169 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q2 2014, down from 171 in Q1 2014.
  • Funds reported $790M of Ariad Pharmaceuticals Inc stock for Q2 2014, down 9.9% quarter-over-quarter.
  • 27 funds opened new Ariad Pharmaceuticals Inc positions in Q2 2014 and 29 closed out, a net change of -2 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q2 2014 was AQR Capital Management, an estimated $20.4M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q2 2014 was Slate Path Capital, an estimated $53.4M sold.

Based on aggregated 13F filings for Q2 2014.